Citation Impact
Citing Papers
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
2010 StandoutNobel
Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization
2005 StandoutNobel
MHC-Restricted Cytotoxic T Cells: Studies on the Biological Role of Polymorphic Major Transplantation Antigens Determining T-Cell Restriction-Specificity, Function, and Responsiveness
1979 StandoutNobel
CD4+ Tregs and immune control
2004 StandoutNobel
Cloning of a new cytokine that induces IFN-γ production by T cells
1995 StandoutNature
Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection
1988 StandoutNature
Single-Molecule Discrimination of Discrete Perisynaptic and Distributed Sites of Actin Filament Assembly within Dendritic Spines
2010 StandoutNobel
Hypoxia-Inducible Erythropoietin Signaling in Squamous Dysplasia and Squamous Cell Carcinoma of the Uterine Cervix and Its Potential Role in Cervical Carcinogenesis and Tumor Progression
2003
Regulated portals of entry into the cell
2003 StandoutNature
Murine cytotoxic T-cell response to alphavirus is associated mainly withH- 2D k
1978
Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.
1996 StandoutNobel
Protein folding in the cell
1992 StandoutNature
Erythropoietin regulates tumour growth of human malignancies
2003
Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
1995 StandoutNobel
Virus-induced autoantibody response to a transgenic viral antigen
1990 StandoutNatureNobel
DYSREGULATION OF GROWTH FACTOR‐RECEPTOR SYSTEM IN CELLULAR TRANSFORMATION
1988
Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo
2005
Myocardial Reperfusion Injury
2007 Standout
Erythropoietin and Erythropoietin Receptor
1999
The Proteasome Regulates Receptor-mediated Endocytosis of Interleukin-2
2001
Interleukin 2 Receptors and Detergent-Resistant Membrane Domains Define a Clathrin-Independent Endocytic Pathway
2001
HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release.
1995 StandoutNobel
Extrathymic positive selection of αβ T-cell precursors in nude mice
1992 StandoutNatureNobel
Anemia of Chronic Disease
2005 Standout
Mouse cytolytic T lymphocytes induced by xenogeneic rat stimulator cells exhibit specificity for H-2 complex alloantigens.
1977 StandoutNobel
H-2-restricted cytotoxic effectors generated in vitro by the addition of trinitrophenyl-conjugated soluble proteins
1978
Autocrine production of extracellular catalase prevents apoptosis of the human CEM T-cell line in serum-free medium.
1993
Generation of cytolytic T lymphocytes after reovirus infection: role of S1 gene.
1979 StandoutNobel
Immunological Surveillance of Tumors in the Context of Major Histocompatibility Complex Restriction of T Cell Function
1984 StandoutNobel
Autocrine growth and tumorigenicity of interleukin 2-dependent helper T cells transfected with IL-2 gene.
1989
The mouse T cell receptor: Structural heterogeneity of molecules of normal T cells defined by Xenoantiserum
1983 StandoutNobel
Cytotoxic T lymphocytes induced in mice by inactivated influenza virus vaccine
1977 Nature
Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.
1992 StandoutNobel
The Murine Sarcoma Virus-Induced Tumor: Exception or General Model in Tumor Immunology?
1977
A Nondeletional Mechanism of Thymic Self Tolerance
1989 StandoutScienceNobel
Retroviral expression of the human IL-2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity.
1987
Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter.
1989 StandoutNobel
The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family
1985 StandoutNobel
Regulation of Receptor Fate by Ubiquitination of Activated β 2 -Adrenergic Receptor and β-Arrestin
2001 StandoutScienceNobel
Tolerance induction by thymic medullary epithelium.
1992 StandoutNobel
H-2 Mutations: Their Genetics and Effect on Immune Functions
1978
Phenotypic Analysis of Antigen-Specific T Lymphocytes
1996 StandoutScience
Interspecies exchange of β 2-microglobulin and associated MHC and differentiation antigens
1981
Activity-Dependent Redistribution and Essential Role of Cortactin in Dendritic Spine Morphogenesis
2003
Clonal Deletion Versus Clonal Anergy: The Role of the Thymus in Inducing Self Tolerance
1990 StandoutScienceNobel
Antigenic Tumor Cell Variants Obtained with Mutagens
1983
Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells.
1991 StandoutNobel
Intracellular maturation and transport of the SV5 type II glycoprotein hemagglutinin-neuraminidase: specific and transient association with GRP78-BiP in the endoplasmic reticulum and extensive internalization from the cell surface.
1989
Mhc RESTRICTION AND Ir GENES
1982
Antiviral antibodies inhibit the lysis of tumour cells by anti-H–2 sera
1976 NatureNobel
Interleukin‐2 is essential for CD4+CD25+ regulatory T cell function
2004
Thymic Requirement for Clonal Deletion During T Cell Development
1989 Science
Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses
2001 StandoutNobel
Reciprocal stimulation of negatively selected high-responder and low-responder T cells in virus-infected recipients.
1979 StandoutNobel
Complex formation of class I transplantation antigens and a viral glycoprotein.
1983 StandoutNobel
Thymus dictates major histocompatibility complex (MHC) specificity and immune response gene phenotype of class II MHC-restricted T cells but not of class I MHC-restricted T cells.
1984
A third rearranged and expressed gene in a clone of cytotoxic T lymphocytes
1984 StandoutNatureNobel
CD4+ Tregs and immune control
2004 StandoutNobel
Serum β2-microglobulin binds to a T-cell differentiation antigen and increases its expression
1984 StandoutNatureNobel
Significance of the proline assay in the study of anti-MSV cell-mediated immune reactions
1979
Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype.
1978 StandoutNobel
Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells.
1984
Requirement for Generation of H 2 O 2 for Platelet-Derived Growth Factor Signal Transduction
1995 StandoutScience
The HLA-dependent expression of testis-organizing H-Y antigen by human male cells
1978 StandoutNobel
Interleukin 2 receptor-targeted cytotoxicity. Interleukin 2 receptor-mediated action of a diphtheria toxin-related interleukin 2 fusion protein.
1988
Alpha/beta T-cell antigen receptor gene and protein expression occurs at early stages of thymocyte differentiation.
1988 StandoutNobel
Joint recognition by cytotoxic T cells of inactivated Sendai virus and products of the major histocompatibility complex.
1977 Nobel
Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance
2002 StandoutNobel
Endocytosis of urokinase-plasminogen activator inhibitor type 1 complexes bound to a chimeric transmembrane urokinase receptor.
1994 StandoutNobel
H-2-linked control of cytotoxic T-cell responsiveness to alphavirus infection. Presence of H-2Dk during differentiation and stimulation converts stem cells of low responder genotype to T cells of responder phenotype.
1979
H‐2‐linked murine cytotoxic T cell responses specific for sendai virus‐infected cells
1978
IMMUNOGENETIC STUDIES ON METH‐A‐VACCINIA TUMOUR CELLS IN VIVO AND IN VITRO*
1977
Influence of the Major Histocompatibility Complex on T-Cell Activation
1979
Immunogenetic analysis ofH-2 mutations
1977
In vitro induction of T-lymphocyte-mediated cytotoxicity by infectious murine type C oncornaviruses.
1979
G 1 Events and Regulation of Cell Proliferation
1989 StandoutScience
Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.
1985
Major Histocompatibility Complex Restricted Cell-Mediated Immunity
1978
Cytotoxicity against tumour-associated antigens not H–2 restricted
1977 Nature
Experiments and Speculation on Antiviral Specificity of T and B Cells
1981
Association of Mouse Major Histocompatibility and Rauscher Murine Leukaemia Virus Envelope Glycoprotein Antigens on Leukaemia Cells and their Recognition by Syngeneic Virus‐Immune‐Cytotoxic T‐Lymphocytes
1978
Different rules govern help for cytotoxic T cells and B cells
1978 StandoutNatureNobel
A one-receptor view of T-cell behaviour
1981 Nature
Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
1985 Standout
H–2 restriction and non-restriction of T-cell-mediated cytotoxicity against mouse mammary tumour targets
1978 Nature
Cross-reactive lysis of trinitrophenyl (TNP)-derivatized H-2 incompatible target cells by cytolytic T lymphocytes generated against syngeneic TNP spleen cells.
1976
Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus‐induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells
1976
Thymocytes appear to ignore class I major histocompatibility complex antigens expressed on thymus epithelial cells
1984
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
1986 StandoutNature
The In Vitro Generation of Effector Lymphocytes and Their Employment in Tumor Immunotherapy
1983
Multiple H-2-linked immune response gene control of H-2D- associated T-cell-mediated lympholysis to trinitrophenyl-modified autologous cells: Ir-like genes mapping to the left of I-A and within the I region
1976
H–2 Antigens on a murine lymphoma are associated with additional proteins
1978 StandoutNatureNobel
Biological Function of HLA
1978
Biological significance of alloreactivity: T cells stimulated by Sendai virus-coated syngeneic cells specifically lyse allogeneic target cells.
1978 StandoutNobel
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
1990 StandoutScience
Heterogeneity of the cytotoxic response of thymus-derived lymphocytes after immunization with influenza viruses.
1977 StandoutNobel
Interleukin-2: Inception, Impact, and Implications
1988 StandoutScience
Works of V Duprez being referenced
Activation of the Mitogen-activated Protein Kinases Erk1/2 by Erythropoietin Receptor via a Gi Protein βγ-Subunit-initiated Pathway
2003
Physical and Functional Interaction between p72 and Erythropoietin Receptor
1998
The Signal Transduction Pathway of Erythropoietin Involves Three Forms of Mitogen‐Activated Protein (MAP) Kinase in UT7 Erythroleukemia Cells
1995
Thrombopoietin stimulates cortactin translocation to the cytoskeleton independently of tyrosine phosphorylation
2001
Thymectomized, irradiated, and bone marrow-reconstituted chimeras have normal cytolytic T lymphocyte precursors but a defect in lymphokine production.
1984
Autocrine growth stimulation of a human T-cell lymphoma line by interleukin 2.
1985
RELATIONSHIPS BETWEEN H‐2 AND VIRAL ANTIGENS IN MURINE ONCORNAVIRUS‐INDUCED TUMOURS*
1977
H–2 region product as determinant in immune cytolysis of syngeneic tumour cells by anti-MSV T lymphocytes
1976 Nature
Stimulation of secondary anti-MSV cytolytic T lymphocytes with MBL-2 reconstituted membranes.
1983
Studies on the nature of the cell surface antigen reacting with cytolytic T lymphocytes in murine oncornavirusinduced tumors
1978
Generation of cytolytic T lymphocytes in thymectomized, irradiated, and bone marrow-reconstituted mice.
1982
Cell‐mediated anti‐tumor response in the RL♂ 1 system I. T nature, H‐2 Dd involvement and antigenic specificity of the effector cells
1978
Thrombopoietin stimulates cortactin translocation to the cytoskeleton independently of tyrosine phosphorylation
2001
High-affinity interleukin 2 receptor alpha and beta chains are internalized and remain associated inside the cells after interleukin 2 endocytosis.
1992
Exclusive involvement of H-2D(b) or H-2K(d) product in the interaction between T-killer lymphocytes and syngeneic H-2(b) or H-2(d) viral lymphomas
1977
Down-regulation of high affinity interleukin 2 receptors in a human tumor T cell line. Interleukin 2 increases the rate of surface receptor decay.
1988
Receptor-mediated endocytosis of interleukin 2 in a human tumor T cell line. Degradation of interleukin 2 and evidence for the absence of recycling of interleukin receptors.
1986